Skip to content
lsd.com

Indication

Stimulant-Use Disorder

2 registered trials testing Psilocybin for this indication, none currently recruiting.

Sponsors register this under 2 different names, all collected here: Stimulant Use Disorder · Stimulant-Use Disorder

2
Registered trials
0
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Stimulant-Use Disorder trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Stimulant-Use Disorder

TrialStatusPhaseSubstanceSites
PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy StudyNCT06666010 · Filament Health Corp.Not yet recruitingPhase 2psilocybin—
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use DisorderNCT05322954 · University of Wisconsin, MadisonTerminatedPhase 1psilocybin1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.